Stocks and Investing Stocks and Investing
Fri, July 18, 2014
Thu, July 17, 2014

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $46 on, Jul 17th, 2014


Published on 2024-10-25 05:27:05 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $44 to $46 on, Jul 17th, 2014.

Jayson has made no other calls on ABT in the last 4 months.



There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Jayson's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jayson


  • Matt Miksic of "Credit Suisse" Upgraded from Hold to Buy on, Monday, May 19th, 2014
Contributing Sources